5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide

5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Suppliers list
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: NCE Biomedical Co.,Ltd.  
Tel: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Email:
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: Shanghai Aladdin Bio-Chem Technology Co.,LTD  
Tel: 400-6206333 13167063860
Email: anhua.mao@aladdin-e.com

5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide manufacturers

  • LY2183240 powder
  • LY2183240 powder pictures
  • $29.00
  • 2021-11-15
  • CAS:874902-19-9
  • Min. Order: 1KG
  • Purity: 99%
  • Supply Ability: 500ton/Month
5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Basic information
Product Name:5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide
Synonyms:LY 2183240;LY-2183240 MN-25;1H-Tetrazole-1-carboxamide, 5-([1,1′-biphenyl]-4-ylmethyl)-N,N-dimethyl-;5-Biphenyl-4-ylmethyl-tetrazole-1-carboxylic acid dimethylamide;N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide;5-(biphenyl-4-ylMethyl)-N,N-diMethyl-1H-tetrazole-1-carboxaMide;LY2183240/LY-2183240;CS-752
CAS:874902-19-9
MF:C17H17N5O
MW:307.35
EINECS:
Product Categories:
Mol File:874902-19-9.mol
5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Structure
5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Chemical Properties
Melting point 87-88℃
Boiling point 506.1±53.0 °C(Predicted)
density 1.21
storage temp. Sealed in dry,2-8°C
solubility Soluble in DMSO (greater than 25 mg/ml) or in Ethanol (up to 15 mg/ml).
pka0.01±0.10(Predicted)
form White to off-white solid.
color White
Stability:Stable for 1 year as supplied. Solutions in DMSO of ethanol may be stored at -20°C for up to 1 month
Safety Information
Hazard Codes Xn
Risk Statements 22
MSDS Information
5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Usage And Synthesis
DescriptionLY-2183240 (874902-19-9) is highly potent inhibitor of cellular anandamide uptake (IC50 = 0.27nM1, 15nM2). LY-2183240 has also been found2-4 to be an inhibitor of fatty acid amide hydrolase (FAAH) – IC50 = 14nM4, diacylglycerol lipase (DAGL) and monoacylglycerol lipase (MAGL) – IC50 = 5.3 nM3.
UsesLY2183240 is a potent inhibitor of FAAH activity, and the uptake and enzymatic hydrolysis of anandamide. Synthetic Cannabinoids
DefinitionChEBI: N,N-dimethyl-5-[(4-phenylphenyl)methyl]-1-tetrazolecarboxamide is a member of biphenyls.
Biological ActivityNovel and highly potent blocker of anandamide uptake (IC 50 = 270 pM). Inhibits fatty acid amide hydrolase (FAAH) activity (IC 50 = 12.4 nM). Following i.p. administration in rats, increases brain anandamide concentration and exerts antinociceptive effects in formalin model of pain.
in vivo

LY2183240 (3-30mg/kg; i.p.) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms[1].

Animal Model:Male Sprague-Dawley rats (Formalin Pain Model)[1]
Dosage:3, 10, 30 mg/kg
Administration:I.p.
Result:Dose-dependently attenuated formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms.
References[1] S A MOORE. Identification of a high-affinity binding site involved in the transport of endocannabinoids.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102 49: 17852-17857. DOI:10.1073/pnas.0507470102
[2] GIORGIO ORTAR . Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: A critical revisitation[J]. European Journal of Medicinal Chemistry, 2008, 43 1: Pages 62-72. DOI:10.1016/j.ejmech.2007.02.023
[3] JESSICA P. ALEXANDER  Benjamin F C. The Putative Endocannabinoid Transport Blocker LY2183240 Is a Potent Inhibitor of FAAH and Several Other Brain Serine Hydrolases[J]. Journal of the American Chemical Society, 2006, 128 30: 9699-9704. DOI:10.1021/ja062999h
[4] AMY K DICKASON-CHESTERFIELD. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.[J]. Cellular and Molecular Neurobiology, 2006, 26 4-6: 407-423. DOI:10.1007/s10571-006-9072-6
5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide Preparation Products And Raw materials
Tag:5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide(874902-19-9) Related Product Information
Simvastatin EPA LY 171883 Zileuton 3,3',5,5'-Tetramethylbenzidine dihydrochloride Biphenyl Bifenthrin BIFENAZATE FIREMASTER BP-6 Thiamethoxam 1H-Tetrazole, 5-(p-methylbenzyl)- 5-[[(1,1'-Biphenyl)-4-yl]methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide